Endur-Amide Sustained Release NIacinamide 500 mg
60/100
Review before taking
- Niacinamide: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacinamide: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
This product received a low safety score because the amount of niacinamide it contains is over 14 times the recommended maximum daily limit.
Label Data
1 Tablet(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
500 mg
(2500% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 14.3× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Other Ingredients
Carnauba Wax
Vegetable Stearine
Magnesium Stearate
Silica
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Sugar Free
Product Information
📋 Directions for Use
DIRECTIONS: As a dietary supplement, take one to three tablets daily with food or drink. Do not exceed recommended dose without consulting a physician.
⚠️ Warnings & Precautions
Keep out of reach of children
🧪 Formulation Notes
(CONTAINS VEGETABLE STEARINE FROM SOYBEAN OIL)
(Nicotinamide)
Contains no salt, sugar, starch, preservatives, artificial color or flavorings.
Additional Information
These tablets are specially manufactured to release the dietary ingredient continuously over a 6-8 hour period.
12502
Store at room temperature.
EP
Product Details
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100